Matthew T. Wiley is CCO at Foamix Pharmaceuticals Ltd. (FOMX). They have made 1 open-market trade across 1 company since 2019, most recently 2026-09-14.
CIK 0001759703
1 open-market purchase totalling $101K since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DFTX | SELL · 10b5-1 | 2026-06-25 | 2026-06-26 | $45.03 | $129K | +7.2% | -5.6% | -18.7% |
| BTAI | SELL · 10b5-1 | 2024-10-03 | 2024-10-03 | $0.55 | $3K | +3.4% | +17.3% | -28.7% |
| BTAI | SELL · 10b5-1 | 2024-09-16 | 2024-09-17 | $0.69 | $148 | -5.8% | -10.9% | -36.5% |
| BTAI | SELL · 10b5-1 | 2024-06-17 | 2024-06-18 | $1.26 | $307 | -3.3% | +2.5% | -47.1% |
| BTAI | SELL · 10b5-1 | 2024-04-04 | 2024-04-08 | $2.64 | $3K | -1.2% | -17.8% | -58.1% |
| FOMX | BUY | 2019-03-05 | 2019-03-06 | $3.76 | $101K | -1.3% | +3.4% | -32.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.